Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halocarbon Life Sciences is the life sciences business of Halocarbon and a commercial-stage manufacturer and supplier of fluorinated products used in pharmaceutical, biotechnology, and healthcare applications. The company is a global supplier of inhalation anesthetics including sevoflurane and isoflurane for both human and veterinary medicine, and it also provides high-purity fluorochemicals used in peptide synthesis, API manufacturing, and biopharmaceutical processing. Its offerings include GMP-grade finished drug products as well as fluorinated building blocks and process materials such as trifluoroacetic acid and related reagents. The business appears to operate primarily as a specialty manufacturer and strategic supplier rather than a drug discovery biotech with a proprietary clinical pipeline. Halocarbon Life Sciences is part of the broader Halocarbon organization, which also serves electronics and engineered fluids markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halocarbon Life Sciences.